GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Valiant Laboratories Ltd (NSE:VALIANTLAB) » Definitions » EPS (Basic)

Valiant Laboratories (NSE:VALIANTLAB) EPS (Basic) : ₹-0.96 (TTM As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Valiant Laboratories EPS (Basic)?

Valiant Laboratories's basic earnings per share (Basic EPS) for the three months ended in Dec. 2024 was ₹0.54. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2024 was ₹-0.96.

Valiant Laboratories's EPS (Diluted) for the three months ended in Dec. 2024 was ₹0.54. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was ₹-0.96.

Valiant Laboratories's EPS without NRI for the three months ended in Dec. 2024 was ₹0.54. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2024 was -0.96.

During the past 12 months, Valiant Laboratories's average EPS without NRIGrowth Rate was -137.30% per year. During the past 3 years, the average EPS without NRI Growth Rate was -73.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 4 years, Valiant Laboratories's highest 3-Year average EPS without NRI Growth Rate was -73.60% per year. The lowest was -73.60% per year. And the median was -73.60% per year.


Valiant Laboratories EPS (Basic) Historical Data

The historical data trend for Valiant Laboratories's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valiant Laboratories EPS (Basic) Chart

Valiant Laboratories Annual Data
Trend Mar21 Mar22 Mar23 Mar24
EPS (Basic)
7.04 6.33 6.67 0.13

Valiant Laboratories Quarterly Data
Mar21 Mar22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.81 -0.29 -0.12 -1.09 0.54

Valiant Laboratories EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Valiant Laboratories's Basic EPS for the fiscal year that ended in Mar. 2024 is calculated as

Basic EPS (A: Mar. 2024 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(3.196-0)/43.450
=0.07

Valiant Laboratories's Basic EPS for the quarter that ended in Dec. 2024 is calculated as

Basic EPS (Q: Dec. 2024 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(23.451-0)/43.428
=0.54

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-0.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Valiant Laboratories  (NSE:VALIANTLAB) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Valiant Laboratories EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Valiant Laboratories's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


Valiant Laboratories Business Description

Traded in Other Exchanges
Address
Mulund Goregaon Link Road, 104, Udyog Kshetra, Mulund, MH, IND, 400080
Valiant Laboratories Ltd is an Active Pharmaceutical Ingredient (API)/Bulk Drug manufacturing company with having focus on manufacturing Paracetamol. Paracetamol is one of the widely used analgesics globally and is recommended as the first-line therapy in pain conditions by the World Health Organization. Paracetamol has several applications such as usage in the treatment of headaches, muscle aches, arthritis, backaches, toothaches, colds, and fever. It manufactures Paracetamol in various grades such as IP/BP/EP/USP, as per the pharmacopeia requirements of its customers.

Valiant Laboratories Headlines

No Headlines